Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Xalatan
Generic name / active ingredient
latanoprost
Dosage-form class
Ophthalmic solution: 0.005% (50 mcg/mL); this dossier precisely displays NDC 58151-419-35, 125 mcg/2.5 mL and one 2.5 mL bottle
Route
Ophthalmic use
Record reviewed
2026-08-21

Copy from the pack in hand

Source-linked reading points

  • 0.005% and 50 mcg/mL are two label formats for the concentration of this eye-drop solution; 2.5 mL is the stated bottle volume. They help identify the exact product, not calculate how many drops anyone should use, how long it lasts or whether to make up use.
  • Eye drops cannot be self-combined, alternated or substituted merely because they mention glaucoma, eye pressure or eye drops. This label has specific checks involving other prostaglandin eye products, other drops and contact lenses; have an ophthalmologist or pharmacist review the actual bottles and complete eye/systemic medicine list.
  • A dropper bottle, cap, volume and label image only help identify a source. They cannot authenticate a product, show that it is another latanoprost presentation or confirm current storage and handling requirements. Opening, storage, spacing from another eye drop, contact lenses and missed-use questions must follow the current label and professional instructions for the exact product in hand.
  • The label includes warnings about iris, periocular tissue/eyelash changes, intraocular inflammation, macular oedema and infection. With vision change, marked eye pain, redness/swelling, injury or another acute eye concern, use local ophthalmic or urgent-care pathways promptly; this page does not decide self-continuation, pause or switching.

Reviewed presentation examples — compare every field

  • 0.005% (50 mcg/mL); 125 mcg/2.5 mL; one 2.5 mL bottleNDC 58151-419-35

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-21
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image